PR Greipp
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 11
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
-
- Protein Degradation and Inhibitors 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Rafaël Fonseca (7 shared papers)MA Gertz (5 shared papers)RA Kyle (6 shared papers)MQ Lacy (7 shared papers)MR Litzow (7 shared papers)TE Witzig (6 shared papers)S. Vincent Rajkumar (5 shared papers)Angela Dispenzieri (3 shared papers)
- Journals
- Bone Marrow Transplantation (7 papers)Leukemia (3 papers)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
PR Greipp
12 papers receiving 640 citations
Peers
Comparison fields: 5 of 45
- Hematology 607
- Genetics 104
- Oncology 260
- Molecular Biology 397
- Transplantation 4
Countries citing papers authored by PR Greipp
This map shows the geographic impact of PR Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PR Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PR Greipp more than expected).
Fields of papers citing papers by PR Greipp
This network shows the impact of papers produced by PR Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PR Greipp. The network helps show where PR Greipp may publish in the future.
Co-authors
The 25 scholars most cited alongside PR Greipp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 140 | |
| 2 | 2001 | 109 | |
| 3 | 1997 | 77 | |
| 4 | Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial. | 1995 | 68 |
| 5 | 1999 | 56 | |
| 6 | 2000 | 55 | |
| 7 | 2010 | 42 | |
| 8 | 1999 | 41 | |
| 9 | 2000 | 33 | |
| 10 | 1999 | 31 | |
| 11 | 1999 | 29 | |
| 12 | Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. | 1994 | 3 |
About PR Greipp
PR Greipp is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 684 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Cancer Treatment and Pharmacology (4 papers), Protein Degradation and Inhibitors (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Hematology (607 citations), Genetics (104 citations), Oncology (260 citations), Molecular Biology (397 citations) and Transplantation (4 citations). PR Greipp has collaborated with scholars based in United States. Frequent co-authors include Rafaël Fonseca, MA Gertz, RA Kyle, MQ Lacy, MR Litzow, TE Witzig, S. Vincent Rajkumar, Angela Dispenzieri, Susan M. Geyer and Brian Van Ness. Their work appears in journals such as Bone Marrow Transplantation, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.